Developer docs
API playgroundTry for free, no card

Search company profiles

Fluidic Analytics

Full company profile

uuid0000uox

Namestring
Fluidic Analytics
Legal namestring
Fluidic Sciences Ltd
Websiteurl
fluidic.com
Company typeenum
Private
Founded yearint
2024
Descriptiontext

Fluidic Analytics operates a portfolio of protein interaction analysis tools built around its proprietary Microfluidic Diffusional Sizing (MDS) technology, which was developed at the University of Cambridge chemistry department and exploits laminar flow in microfluidic channels to measure protein hydrodynamic radius, binding affinity (KD), stoichiometry, and concentration directly in solution without purification or immobilization. The company is in the process of transitioning its commercial operations under the Fluidic Sciences Ltd entity, founded in 2024 by a small group of local investors to commercialize the MDS platform, while continuing to operate from Royston, UK, with a team of approximately 13–50 employees. Its product suite centers on the Fluidity One-M benchtop instrument, paired with single-use chip-plate consumables, protein labelling kits, the Fluidity Insight cloud analysis platform (with ML-guided and Bayesian assay design), and a growing menu of dedicated assays (NeSt for disordered proteins, SAffCon for serum antibody profiling, MAffCon for membrane proteins).

The business model combines one-time instrument sales with recurring consumables revenue (chip-plates and labelling kits, both shipped with a 3-month minimum shelf life), an annual SaaS subscription for Fluidity Insight, and optional professional services for installation and maintenance. Distribution is hybrid: direct enterprise sales for global accounts complemented by three regional distributors covering Eastern Europe and Austria (LKB), Japan (M&S TechnoSystems), and Taiwan and China (CS Biotech), giving the company coverage of roughly 15 countries despite its small headcount. In September 2025 the company acquired Sphere Bio, adding the Cyto-Mine Chroma picodroplet microfluidic single-cell screening platform and shifting the portfolio toward an end-to-end "cells to molecules" workflow. Primary customer segments are academic research institutions and biopharmaceutical companies, with an emerging clinical-laboratory vertical supported by the SAffCon assay. The firm has historically raised approximately $40.7M in venture funding (notably a $31M Series 3 in November 2018 led by Molten Ventures), though the post-restructuring Fluidic Sciences Ltd entity has not disclosed institutional venture rounds to date.

Short descriptiontext

Fluidic Analytics (operating as Fluidic Sciences Ltd) develops and commercializes the Microfluidic Diffusional Sizing (MDS) benchtop platform and consumables for measuring protein interactions in solution, serving academic researchers, biopharmaceutical companies, and clinical laboratories across roughly 15 countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersCambridge, United Kingdom
HQ citystring
Cambridge
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
protein interaction analysis, microfluidic lab instruments, biophysical characterization tools, single-cell screening platforms, protein analysis consumables
Industry1 code
PRIMARYHLAGAIAD
Liquid Handling & Laboratory Automation (Pipettes, Robots, Workstations)
NAICS code1 code
  • Analytical Laboratory Instrument Manufacturing334516
SIC code1 code
  • Laboratory Analytical Instruments3826
Product category
Laboratory Instruments for Protein Interaction Analysis
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Instrument Sales
TypeHardware Sales
Description

Sale of Fluidity One-M instruments for protein interaction analysis. Instruments include 12-month warranty covering parts, labour, and technical support.

fluidic.com
2Consumables
TypeHardware Sales
Description

Recurring revenue from single-use chip-plates and protein labelling kits. Consumables shipped with minimum 3-month shelf life.

fluidic.com
3Cloud-based Software (SaaS)
TypeSubscription Recurring
Description

Cloud-based software platform (Fluidity Insight) for data analysis and machine learning-guided assay design.

fluidic.com
4Professional Services
TypeProfessional Services
Description

Field service engineers provide installation, maintenance, and repair services. Annual maintenance recommended post-warranty.

fluidic.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure
Pricing details4 tiers
1Instrument purchase - Fluidity One-M
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

Instruments sold with 12-month warranty. Price quoted on request. EXW shipping terms with buyer paying freight, duties, insurance.

fluidic.com
2Chip-plates consumables
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Two boxes each containing eight chip-plates. Consumables shipped with minimum 3-month shelf life.

fluidic.com
3Protein Labelling Kit
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Kit containing material sufficient for six labelling reactions. Shipped with minimum 3-month shelf life.

fluidic.com
4Cloud Service (Fluidity Insight)
ModelSubscriptionBilling cadenceAnnual
Notes

SaaS platform for data analysis. License to access and use cloud service during contract term.

fluidic.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Sphere Bio
Description

High-throughput single-cell screening brand offering Cyto-MINE Chroma platform, picodroplet microfluidic technology, consumables, and reagents for biologics discovery, cell engineering, and synthetic biology applications.

fluidic.com
Core offering1 text field

Fluidic Sciences designs, develops and manufactures benchtop microfluidic instruments and single-use consumables for protein interaction analysis. Its proprietary Microfluidic Diffusional Sizing (MDS) technology measures binding affinity (KD), hydrodynamic radius, concentration and stoichiometry directly in solution, without purification or immobilization, in approximately 25 minutes. The portfolio also includes the Fluidity Insight cloud analysis platform and, following the 2025 acquisition of Sphere Bio, the Cyto-Mine Chroma picodroplet microfluidic platform for high-throughput single-cell screening.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Full binding curve and KD determined in 25 minutes
+3 more records
Product overview1 text field

Fluidic Sciences offers an integrated portfolio of protein interaction analysis products built around their proprietary Microfluidic Diffusional Sizing (MDS) technology. The core offering includes the Fluidity One-M benchtop instrument paired with the Fluidity Insight cloud-based analysis platform featuring machine learning-guided assays and Bayesian analysis. Following the 2025 acquisition of Sphere Bio, the portfolio expanded to include the Cyto-Mine Chroma picodroplet microfluidic platform for single-cell analysis. Supporting consumables include chip-plates and protein labeling kits. Specialized assays (NeSt, SAffCon, MAffCon) address specific applications including intrinsically disordered proteins, serum antibody profiling, and membrane protein characterization.

Product and service8 records
1Fluidity One-M
CategoryLaboratory instrument
Description

Benchtop instrument using Microfluidic Diffusional Sizing (MDS) to measure protein interactions directly in solution. Delivers binding affinity (KD), hydrodynamic radius, concentration, and stoichiometry simultaneously in approximately 25 minutes from a 4 µL sample, without purification or immobilization. Targeted at academic research labs, biopharmaceutical R&D teams, and clinical laboratories.

2Fluidity Insight
CategoryCloud software platform
Description

Cloud-based SaaS analysis platform that simplifies assay development for protein interaction analysis using machine learning-guided experimental design and Bayesian inference. License is provided on an annual subscription basis for the duration of the contract term.

3Cyto-Mine Chroma
CategorySingle-cell screening platform
Description

High-throughput picodroplet microfluidic platform from the acquired Sphere Bio business for single-cell isolation and analysis. Each picodroplet encapsulates a cell as an ultra-miniaturized test tube, enabling large-scale single-cell experiments in biologics discovery, cell engineering and synthetic biology.

4Fluidity One-M Chip-plates
CategoryConsumable
Description

Single-use disposable microfluidic chip-plates with PEG-displaying anti-adhesive coating for use with the Fluidity One-M instrument. Sold in boxes of eight chip-plates, shipped with a minimum 3-month shelf life, designed to prevent cross-contamination between measurements.

5Protein Labelling Kit - Amine Reactive (Red 647 nm)
CategoryConsumable
Description

Fluorescent labelling kit for tagging proteins for use in Fluidity One-M MDS experiments. Each kit contains material sufficient for six labelling reactions and is shipped with a minimum 3-month shelf life.

6Neuroaffinity and Stoichiometry (NeSt) Assay
CategoryApplication assay
Description

Dedicated MDS assay for determining both binding affinity and stoichiometry of protein interactions without external calibrants. Particularly suited to intrinsically disordered proteins such as alpha-synuclein, using Bayesian inference to provide a complete view of parameter space.

7Serum Affinity and Concentration (SAffCon) Assay
CategoryApplication assay
Description

Assay for measuring binding affinity and concentration of antibodies directly in whole biofluids including undiluted serum, requiring no pre-dilution or pretreatment of the sample.

8Membrane protein Affinity and Concentration (MAffCon) Assay
CategoryApplication assay
Description

Assay enabling absolute measurements of oncoprotein levels and antibody interactions in native lipid environments, including measurements in liposomes, lipid rafts, or nanodiscs.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-09-04
Description

Fluidic Sciences acquired the business and assets of Sphere Bio in September 2025. This combined portfolio unites Fluidic Sciences' in-solution Microfluidic Diffusional Sizing (MDS) technology with Sphere Bio's proprietary picodroplet-microfluidic platforms, Cyto-Mine® Chroma, and high-throughput assays. The acquisition delivers end-to-end insight from cells to molecules.

2LKB
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Regional distributor for Eastern Europe covering Bosnia and Herzegovina, Bulgaria, Croatia, Serbia, Slovenia, Romania, Montenegro, Macedonia, Kosovo, Albania, and Austria. Provides product information, demonstrations, training, and support services for Fluidic Sciences products in the region.

fluidic.com
3M&S TechnoSystems Inc.
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Regional distributor for Japan providing product information, demonstrations, training, and support services for Fluidic Sciences products. Located in Osaka, Japan.

fluidic.com
4CS Biotech
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Regional distributor for Taiwan and China providing product information, demonstrations, training, and support services for Fluidic Sciences products.

fluidic.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Sartorius owns FortéBio, whose BLI (Bio-Layer Interferometry) Octet platform is the most established label-free protein interaction analysis tool. Competes head-on with Fluidity One-M for protein binding affinity and kinetics workflows in pharma and academia.

TypeDirect peer
Description

Cytiva's Biacore SPR systems are the gold standard for surface-based protein interaction kinetics, occupying large installed bases in pharma and academic biophysics. Directly competes with MDS on binding affinity measurement but uses a fundamentally different surface-immobilization approach that MDS positions against.

TypeDirect peer
Description

NanoTemper's Monolith series (MST, MicroScale Thermophoresis) provides label-free protein interaction analysis in solution with low sample consumption. Closely comparable in value proposition to MDS, addressing the same use cases in biologics discovery and characterization.

TypeDirect peer
Description

Wyatt's DLS/SEC-MALS instruments (now under Malvern Panalytical) measure protein hydrodynamic radius and absolute molar mass. Adjacent technology to MDS for protein sizing, and an established competitor in protein characterization workflows.

TypeEmerging player
Description

Refeyn commercializes mass photometry for single-molecule mass measurement of proteins and other biomolecules. Emerging label-free, low-sample tool that overlaps with MDS on native-state protein sizing and binding analysis.

TypeDirect peer
Description

Unchained Labs builds protein analysis tools targeting biologics development workflows, including stability, aggregation, and interactomics. Competes for similar biopharma capex budget on protein characterization benches.

TypeBroad incumbent
Description

Molecular Devices supplies a broad portfolio of biophysics and screening instruments including high-content screening and protein interaction tools. Competes indirectly with MDS through larger workflow-level deals with biopharma accounts.

TypeBroad incumbent
Description

Bruker offers a broad suite of biophysical and analytical instruments (SPR, MS, NMR) used in structural biology and protein research. A scale incumbent that can bundle alternatives to MDS into large pharma enterprise deals.

TypeEmerging player
Description

Sphere Bio was acquired by Fluidic Sciences in September 2025. Its Cyto-Mine picodroplet single-cell screening platform is now a sister product inside the combined Fluidic Sciences portfolio and a reference point for the broader single-cell microfluidic tool category.

TypeBroad incumbent
Description

10x Genomics' Chromium platform provides droplet-based single-cell isolation and analysis widely used in cell biology and antibody discovery. Comparable to Sphere Bio's Cyto-Mine for high-throughput single-cell screening applications.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles16 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors8 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Fluidic Analytics

Laboratory Instruments for Protein Interaction Analysisfluidic.com

Fluidic Analytics (operating as Fluidic Sciences Ltd) develops and commercializes the Microfluidic Diffusional Sizing (MDS) benchtop platform and consumables for measuring protein interactions in solution, serving academic researchers, biopharmaceutical companies, and clinical laboratories across roughly 15 countries.

What Fluidic Analytics does

Fluidic Analytics operates a portfolio of protein interaction analysis tools built around its proprietary Microfluidic Diffusional Sizing (MDS) technology, which was developed at the University of Cambridge chemistry department and exploits laminar flow in microfluidic channels to measure protein hydrodynamic radius, binding affinity (KD), stoichiometry, and concentration directly in solution without purification or immobilization. The company is in the process of transitioning its commercial operations under the Fluidic Sciences Ltd entity, founded in 2024 by a small group of local investors to commercialize the MDS platform, while continuing to operate from Royston, UK, with a team of approximately 13–50 employees. Its product suite centers on the Fluidity One-M benchtop instrument, paired with single-use chip-plate consumables, protein labelling kits, the Fluidity Insight cloud analysis platform (with ML-guided and Bayesian assay design), and a growing menu of dedicated assays (NeSt for disordered proteins, SAffCon for serum antibody profiling, MAffCon for membrane proteins).

The business model combines one-time instrument sales with recurring consumables revenue (chip-plates and labelling kits, both shipped with a 3-month minimum shelf life), an annual SaaS subscription for Fluidity Insight, and optional professional services for installation and maintenance. Distribution is hybrid: direct enterprise sales for global accounts complemented by three regional distributors covering Eastern Europe and Austria (LKB), Japan (M&S TechnoSystems), and Taiwan and China (CS Biotech), giving the company coverage of roughly 15 countries despite its small headcount. In September 2025 the company acquired Sphere Bio, adding the Cyto-Mine Chroma picodroplet microfluidic single-cell screening platform and shifting the portfolio toward an end-to-end "cells to molecules" workflow. Primary customer segments are academic research institutions and biopharmaceutical companies, with an emerging clinical-laboratory vertical supported by the SAffCon assay. The firm has historically raised approximately $40.7M in venture funding (notably a $31M Series 3 in November 2018 led by Molten Ventures), though the post-restructuring Fluidic Sciences Ltd entity has not disclosed institutional venture rounds to date.

Fluidic Analytics firmographics

Firmographics
Name
Fluidic Analytics
Legal name
Fluidic Sciences Ltd
Website
https://fluidic.com
Company type
Private
Founded year
2024
Operating status
Operating
Headcount range
1–10 employees
Short description
Fluidic Analytics (operating as Fluidic Sciences Ltd) develops and commercializes the Microfluidic Diffusional Sizing (MDS) benchtop platform and consumables for measuring protein interactions in solution, serving academic researchers, biopharmaceutical companies, and clinical laboratories across roughly 15 countries.
Ownership category
akta.pro rank

Fluidic Analytics industry classification

Industry
Product category
Laboratory Instruments for Protein Interaction Analysis
NAICS
Analytical Laboratory Instrument Manufacturing (334516)
SIC
Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAGAIAD
Liquid Handling & Laboratory Automation (Pipettes, Robots, Workstations)

Keywords

  • Protein interaction analysis
  • Microfluidic lab instruments
  • Biophysical characterization tools
  • Single-cell screening platforms
  • Protein analysis consumables

Where Fluidic Analytics is headquartered

Location

Headquarters

HQ city
Cambridge
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Fluidic Analytics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Instrument Sales: Sale of Fluidity One-M instruments for protein interaction analysis. Instruments include 12-month warranty covering parts, labour, and technical support.
  2. Consumables: Recurring revenue from single-use chip-plates and protein labelling kits. Consumables shipped with minimum 3-month shelf life.
  3. Cloud-based Software (SaaS): Cloud-based software platform (Fluidity Insight) for data analysis and machine learning-guided assay design.
  4. Professional Services: Field service engineers provide installation, maintenance, and repair services. Annual maintenance recommended post-warranty.

Pricing tiers

ModelBillingPrice
One time/ perpetual licenseMulti-year contractInstrument purchase - Fluidity One-M
Unit PricingPay-as-you-goChip-plates consumables
Unit PricingPay-as-you-goProtein Labelling Kit
SubscriptionAnnualCloud Service (Fluidity Insight)

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

Fluidic Analytics product offering

Product offering

Core offering

Fluidic Sciences designs, develops and manufactures benchtop microfluidic instruments and single-use consumables for protein interaction analysis. Its proprietary Microfluidic Diffusional Sizing (MDS) technology measures binding affinity (KD), hydrodynamic radius, concentration and stoichiometry directly in solution, without purification or immobilization, in approximately 25 minutes. The portfolio also includes the Fluidity Insight cloud analysis platform and, following the 2025 acquisition of Sphere Bio, the Cyto-Mine Chroma picodroplet microfluidic platform for high-throughput single-cell screening.

Product overview

Fluidic Sciences offers an integrated portfolio of protein interaction analysis products built around their proprietary Microfluidic Diffusional Sizing (MDS) technology. The core offering includes the Fluidity One-M benchtop instrument paired with the Fluidity Insight cloud-based analysis platform featuring machine learning-guided assays and Bayesian analysis. Following the 2025 acquisition of Sphere Bio, the portfolio expanded to include the Cyto-Mine Chroma picodroplet microfluidic platform for single-cell analysis. Supporting consumables include chip-plates and protein labeling kits. Specialized assays (NeSt, SAffCon, MAffCon) address specific applications including intrinsically disordered proteins, serum antibody profiling, and membrane protein characterization.

Differentiator

Problem solved

Functional benefit

Brands

  • Sphere Bio: High-throughput single-cell screening brand offering Cyto-MINE Chroma platform, picodroplet microfluidic technology, consumables, and reagents for biologics discovery, cell engineering, and synthetic biology applications.

Products and services

  • Fluidity One-M Benchtop instrument using Microfluidic Diffusional Sizing (MDS) to measure protein interactions directly in solution. Delivers binding affinity (KD), hydrodynamic radius, concentration, and stoichiometry simultaneously in approximately 25 minutes from a 4 µL sample, without purification or immobilization. Targeted at academic research labs, biopharmaceutical R&D teams, and clinical laboratories.
  • Fluidity Insight Cloud-based SaaS analysis platform that simplifies assay development for protein interaction analysis using machine learning-guided experimental design and Bayesian inference. License is provided on an annual subscription basis for the duration of the contract term.
  • Cyto-Mine Chroma High-throughput picodroplet microfluidic platform from the acquired Sphere Bio business for single-cell isolation and analysis. Each picodroplet encapsulates a cell as an ultra-miniaturized test tube, enabling large-scale single-cell experiments in biologics discovery, cell engineering and synthetic biology.
  • Fluidity One-M Chip-plates Single-use disposable microfluidic chip-plates with PEG-displaying anti-adhesive coating for use with the Fluidity One-M instrument. Sold in boxes of eight chip-plates, shipped with a minimum 3-month shelf life, designed to prevent cross-contamination between measurements.
  • Protein Labelling Kit - Amine Reactive (Red 647 nm) Fluorescent labelling kit for tagging proteins for use in Fluidity One-M MDS experiments. Each kit contains material sufficient for six labelling reactions and is shipped with a minimum 3-month shelf life.
  • Neuroaffinity and Stoichiometry (NeSt) Assay Dedicated MDS assay for determining both binding affinity and stoichiometry of protein interactions without external calibrants. Particularly suited to intrinsically disordered proteins such as alpha-synuclein, using Bayesian inference to provide a complete view of parameter space.
  • Serum Affinity and Concentration (SAffCon) Assay Assay for measuring binding affinity and concentration of antibodies directly in whole biofluids including undiluted serum, requiring no pre-dilution or pretreatment of the sample.
  • Membrane protein Affinity and Concentration (MAffCon) Assay Assay enabling absolute measurements of oncoprotein levels and antibody interactions in native lipid environments, including measurements in liposomes, lipid rafts, or nanodiscs.

Quantifiable outcome

  • Full binding curve and KD determined in 25 minutes
  • +3 more outcomes

Companies that use Fluidic Analytics

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Fluidic Analytics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

Fluidic Analytics partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered flagship and core.

  • Sphere BioflagshipStrategic or Co-development Partner · 4 September 2025Fluidic Sciences acquired the business and assets of Sphere Bio in September 2025. This combined portfolio unites Fluidic Sciences' in-solution Microfluidic Diffusional Sizing (MDS) technology with Sphere Bio's proprietary picodroplet-microfluidic platforms, Cyto-Mine® Chroma, and high-throughput assays. The acquisition delivers end-to-end insight from cells to molecules.
  • LKBcoreChannel Partner/ Reseller/ DistributorRegional distributor for Eastern Europe covering Bosnia and Herzegovina, Bulgaria, Croatia, Serbia, Slovenia, Romania, Montenegro, Macedonia, Kosovo, Albania, and Austria. Provides product information, demonstrations, training, and support services for Fluidic Sciences products in the region.
  • M&S TechnoSystems Inc.coreChannel Partner/ Reseller/ DistributorRegional distributor for Japan providing product information, demonstrations, training, and support services for Fluidic Sciences products. Located in Osaka, Japan.
  • CS BiotechcoreChannel Partner/ Reseller/ DistributorRegional distributor for Taiwan and China providing product information, demonstrations, training, and support services for Fluidic Sciences products.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Fluidic Analytics competitors and assessment

Company assessment

Direct peers

  • Sartorius (FortéBio): Sartorius owns FortéBio, whose BLI (Bio-Layer Interferometry) Octet platform is the most established label-free protein interaction analysis tool. Competes head-on with Fluidity One-M for protein binding affinity and kinetics workflows in pharma and academia.
  • Cytiva (Biacore): Cytiva's Biacore SPR systems are the gold standard for surface-based protein interaction kinetics, occupying large installed bases in pharma and academic biophysics. Directly competes with MDS on binding affinity measurement but uses a fundamentally different surface-immobilization approach that MDS positions against.
  • NanoTemper Technologies: NanoTemper's Monolith series (MST, MicroScale Thermophoresis) provides label-free protein interaction analysis in solution with low sample consumption. Closely comparable in value proposition to MDS, addressing the same use cases in biologics discovery and characterization.
  • Wyatt Technology (Malvern Panalytical): Wyatt's DLS/SEC-MALS instruments (now under Malvern Panalytical) measure protein hydrodynamic radius and absolute molar mass. Adjacent technology to MDS for protein sizing, and an established competitor in protein characterization workflows.
  • Unchained Labs: Unchained Labs builds protein analysis tools targeting biologics development workflows, including stability, aggregation, and interactomics. Competes for similar biopharma capex budget on protein characterization benches.

Emerging players

  • Refeyn: Refeyn commercializes mass photometry for single-molecule mass measurement of proteins and other biomolecules. Emerging label-free, low-sample tool that overlaps with MDS on native-state protein sizing and binding analysis.
  • Sphere Bio (now part of Fluidic Sciences): Sphere Bio was acquired by Fluidic Sciences in September 2025. Its Cyto-Mine picodroplet single-cell screening platform is now a sister product inside the combined Fluidic Sciences portfolio and a reference point for the broader single-cell microfluidic tool category.

Broad incumbents

  • Molecular Devices (Danaher): Molecular Devices supplies a broad portfolio of biophysics and screening instruments including high-content screening and protein interaction tools. Competes indirectly with MDS through larger workflow-level deals with biopharma accounts.
  • Bruker: Bruker offers a broad suite of biophysical and analytical instruments (SPR, MS, NMR) used in structural biology and protein research. A scale incumbent that can bundle alternatives to MDS into large pharma enterprise deals.
  • 10x Genomics: 10x Genomics' Chromium platform provides droplet-based single-cell isolation and analysis widely used in cell biology and antibody discovery. Comparable to Sphere Bio's Cyto-Mine for high-throughput single-cell screening applications.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Fluidic Analytics social profiles

Digital presence

Fluidic Analytics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Fluidic Analytics leadership team

Management profile

Number of profiles

Profiles16 records

Fluidic Analytics subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Fluidic Analytics funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Fluidic Analytics M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fluidic Analytics

What does Fluidic Analytics do?

Fluidic Sciences designs, develops and manufactures benchtop microfluidic instruments and single-use consumables for protein interaction analysis. Its proprietary Microfluidic Diffusional Sizing (MDS) technology measures binding affinity (KD), hydrodynamic radius, concentration and stoichiometry directly in solution, without purification or immobilization, in approximately 25 minutes. The portfolio also includes the Fluidity Insight cloud analysis platform and, following the 2025 acquisition of Sphere Bio, the Cyto-Mine Chroma picodroplet microfluidic platform for high-throughput single-cell screening.

Is Fluidic Analytics a public or private company?

Fluidic Analytics is a private company. It is classified as venture growth investor backed and is currently operating.

When was Fluidic Analytics founded?

Fluidic Analytics was founded in 2024. It employs 1 to 10 people.

Where is Fluidic Analytics based?

Fluidic Analytics is headquartered in Cambridge, United Kingdom, in the Europe region.

How does Fluidic Analytics make money?

Four revenue lines are on record. Instrument Sales are the primary driver. The others are consumables, cloud-based Software (SaaS) and professional Services.

Who are Fluidic Analytics's main competitors?

Direct peers on record are Sartorius (FortéBio), Cytiva (Biacore), NanoTemper Technologies, Wyatt Technology (Malvern Panalytical) and Unchained Labs. Emerging players are Refeyn and Sphere Bio (now part of Fluidic Sciences). Broad incumbents are Molecular Devices (Danaher), Bruker and 10x Genomics.

Does Fluidic Analytics have an API?

No public API is recorded for Fluidic Analytics.

What industry is Fluidic Analytics in?

Fluidic Analytics's product category is Laboratory Instruments for Protein Interaction Analysis. Its primary akta.pro industry code is HLAGAIAD, Liquid Handling & Laboratory Automation (Pipettes, Robots, Workstations). Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
SelectScienceWhat is Microfluidic Diffusional Sizing?Fluidic Sciences promotes Microfluidic Diffusional Sizing (MDS), a technology for measuring protein binding affinity without surface immobilization. This method allows scientists to determine molecular size, concentration, and stoichiometry directly in solution across various sample types.News-MedicalFluidic Analytics showcases protein analysis expertiseFluidic Analytics will showcase its Fluidity One-W protein analysis instrument at multiple European events in October and November. The instrument uses microfluidic diffusional sizing to measure protein interactions in solution, offering binding kinetics and stoichiometry data. The company plans to release the instrument later in the year.News-MedicalUnlocking the power of proteins to better understand human healthFluidic Analytics CEO Andrew Lynn discusses the company's focus on protein interactions to advance disease understanding. The company's microfluidic technology characterizes binding affinity, concentration, and stoichiometry, and Lynn highlights Europe's role and future growth in life sciences.Royal Academy of EngineeringAcademy announces three leading innovators as Silver MedallistsThe Royal Academy of Engineering will award Silver Medals to Dr Tom Carter, Dr Andrew Lynn, and Dr Sithamparanathan Sabesan for innovations in haptic technology, medical diagnostics, and RFID tracking. Their work includes Ultraleap's touch-free screens, Fluidic Analytics' protein diagnostics, and PervasID's hospital RFID readers. The awards celebrate contributions that boost the UK economy and improve lives.Silicon RepublicEurope Start-up 100: Who are the ones to watch in 2019?Europe's tech ecosystem is growing, with $23bn invested last year and 69 IPOs, up from $5bn and 28 in 2013. European IPOs gained 222% on average versus 42% in the US. A list of 100 start-ups to watch in 2019 is provided.Pulse 2.0Fluidic Analytics Raises $31 Million To Develop Protein Analysis ToolsFluidic Analytics raised $31 million in a financing round led by Draper Esprit, with participation from Delin Ventures, BGF, IQ Capital, and Amadeus Capital Partners. The company will use the funds to commercialize its Fluidity One system and develop further clinical applications for protein analysis.FinSMEsFluidic Analytics Raises $31M in FundingFluidic Analytics, a Cambridge-based protein characterization company, raised $31M in funding led by Draper Esprit. The company will use the funds to continue its lab-tools pipeline and develop clinical applications. The technology aims to aid research into Alzheimer's and drug development.EU-StartupsFluidic Analytics raises €27 million to enhance the understanding of diseases through its protein characterisation platformFluidic Analytics raised €27 million in a financing round led by Draper Esprit, with participation from Delin Ventures, BGF, IQ Capital, and Amadeus Capital Partners. The UK-based biotech will use the funds to commercialize its Fluidity One system and develop clinical applications for protein characterization.UnquoteDraper Esprit leads $31m round for Fluidic AnalyticsDraper Esprit led a $31m funding round for Fluidic Analytics, a UK biotech equipment company, with new investors BGF and Delin Ventures joining. The company will accelerate product commercialization and invest in R&D for new clinical applications. Fluidic is launching its Fluidity One product, which analyzes protein folding and aggregation changes.News-MedicalInnomech develops innovative test station for Fluidic AnalyticsInnomech designed an automated test station for Fluidic Analytics to process up to 96 protein samples per run without operator involvement. The system, based on a Tecan Cavro Omni Flex robot, runs over 24 hours to support R&D and final performance testing of production units.